Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Figs Inc (FIGS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/20/2025: FIGS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $4.61
1 Year Target Price $4.61
| 0 | Strong Buy |
| 1 | Buy |
| 7 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -55.15% | Avg. Invested days 20 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 957.43M USD | Price to earnings Ratio 589 | 1Y Target Price 4.61 |
Price to earnings Ratio 589 | 1Y Target Price 4.61 | ||
Volume (30-day avg) 10 | Beta 1.22 | 52 Weeks Range 3.56 - 7.05 | Updated Date 06/30/2025 |
52 Weeks Range 3.56 - 7.05 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.01 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-06-05 | When After Market | Estimate - | Actual -0.0006 |
Profitability
Profit Margin 0.21% | Operating Margin (TTM) -0.17% |
Management Effectiveness
Return on Assets (TTM) 0.2% | Return on Equity (TTM) 0.31% |
Valuation
Trailing PE 589 | Forward PE 169.49 | Enterprise Value 757540172 | Price to Sales(TTM) 1.71 |
Enterprise Value 757540172 | Price to Sales(TTM) 1.71 | ||
Enterprise Value to Revenue 1.35 | Enterprise Value to EBITDA 80.13 | Shares Outstanding 154267008 | Shares Floating 148924472 |
Shares Outstanding 154267008 | Shares Floating 148924472 | ||
Percent Insiders 5.48 | Percent Institutions 96.88 |
Analyst Ratings
Rating 4 | Target Price 4.61 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold 7 | Sell 2 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Figs Inc
Company Overview
History and Background
Figs Inc. was founded in 2013 by Heather Hasson and Trina Spear, disrupting the traditional medical apparel market with stylish, comfortable, and functional scrubs. They focused on a direct-to-consumer (DTC) model, emphasizing community building and social responsibility.
Core Business Areas
- Apparel: Designs and sells medical apparel including scrubs, lab coats, compression socks, and other related items. Focuses on innovation, comfort, and style.
- Lifestyle: Expands beyond scrubs to offer lifestyle apparel such as outerwear, accessories, and footwear catered to the healthcare professional. Focuses on on and off-duty wear.
- Teams and Organizations: Offering group sales to healthcare systems and organizations, providing bulk orders and custom branding options. Supports volume sales and brand partnerships
Leadership and Structure
Figs Inc. is led by CEO Trina Spear. The organizational structure is built around key departments including design, marketing, sales, operations, and finance.
Top Products and Market Share
Key Offerings
- Scrubs: Figs' core product, designed for comfort, durability, and style. Figs holds a significant market share in the DTC scrubs market, estimated around 25%. Competitors include Careismatic Brands (Cherokee), Landau, and Medline. Scrubs generates the largest percentage of total revenue.
- Lab Coats: Stylish and functional lab coats catering to healthcare professionals. Smaller market share compared to scrubs, with increased competition from traditional uniform suppliers and other DTC brands. Market share data for this product is not publicly specified. Competitors are Alexandra, WonderWink, and Dickies.
- Compression Socks: Designed for comfort and support during long shifts. Has a small but growing market share due to the rise of healthcare professionals needing support. Competitors are Pro Compression, Nurse Mates, and Sockwell.
Market Dynamics
Industry Overview
The medical apparel market is growing, driven by increasing healthcare employment and a shift towards more comfortable and stylish workwear. The rise of DTC brands has disrupted the traditional uniform market.
Positioning
Figs Inc. positions itself as a premium, DTC brand focused on innovation, community, and sustainability. This differentiates it from traditional uniform suppliers and other competitors.
Total Addressable Market (TAM)
The global medical apparel market is estimated to reach approximately $79 billion by 2032. Figs Inc. captures a single-digit percentage of this TAM, with significant growth potential by expanding its product offerings and market reach.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Direct-to-consumer model
- Innovative product design
- Loyal customer base
- Strong community engagement
Weaknesses
- Reliance on DTC model
- Limited product diversification
- Premium pricing
- Supply chain vulnerabilities
- Dependence on marketing spend
Opportunities
- Expand product lines
- International expansion
- Partnerships with healthcare systems
- New distribution channels
- Increase brand awareness
Threats
- Increased competition
- Economic downturn
- Changes in consumer preferences
- Supply chain disruptions
- Rising marketing costs
Competitors and Market Share
Key Competitors
- CBRL
- DGII
- ASO
Competitive Landscape
Figs Inc. has a strong brand and DTC model, but faces competition from established uniform suppliers and other DTC brands. FIGS must continue innovate, be efficient with its business operations and manage its expenses well.
Growth Trajectory and Initiatives
Historical Growth: Figs Inc. has experienced high revenue growth in recent years, driven by its DTC model and innovative products.
Future Projections: Analysts project continued revenue growth for Figs Inc., driven by product expansion and market penetration.
Recent Initiatives: Figs Inc. has recently focused on expanding its product line, improving its supply chain, and increasing its brand awareness.
Summary
Figs Inc. has a strong brand and innovative products, but faces increased competition and must manage its supply chain effectively. The direct-to-consumer model has driven growth, but the company needs to diversify its product lines. Economic downturns and changing consumer preferences could pose challenges. Figs Inc. needs to innovate and adjust well as the landscape is still shifting. Figs Inc. is positioned for long term success with the leadership team in place to support growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
- Market research reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market conditions can change rapidly, and past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Figs Inc
Exchange NYSE | Headquaters Santa Monica, CA, United States | ||
IPO Launch date 2021-05-27 | Co-Founder, CEO & Director Ms. Catherine Eva Spear | ||
Sector Consumer Cyclical | Industry Apparel Manufacturing | Full time employees 303 | Website https://www.wearfigs.com |
Full time employees 303 | Website https://www.wearfigs.com | ||
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.